Navigation Links
Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
Date:10/13/2009

NEW YORK, Oct. 13 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery

http://www.reportlinker.com/p0154807/Reportlinker-Adds-Global-Drug-Manufacturing-Industry-Outlook-to-2010-Marketing-and-Sales-Strategies-and-the-Impact-of-Recession-and-Recovery.html

Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery

    Summary

    "Global Drug Manufacturing Industry Outlook to 2010: Marketing & Sales Strategies and the Impact of Recession and Recovery" is a new report published by Global Markets Direct in association with ICD Research that analyzes how drugs manufacturer's and equipment, materials and service supplier's media spend, marketing and sales strategies & practices and business are being affected by the recession. In an uncertain economic climate this report gives you access to the media channel spending outlooks, media budgets, marketing agency selection criteria, business challenges and sales tactics of leading buyers and suppliers. The report also identifies drug manufacturers and suppliers future growth, M&A and investment expectations. The research is based on an extensive survey of senior and C-level industry executives from our market leading panels.

    Scope

    - The opinions and forward looking statements of over 550 industry executives have been captured in our in-depth survey, of which 65% represent Directors, C-levels & Departmental Heads

    - This report covers data and analysis on media channel spend, marketing and sales practices and industry developments by drugs manufacturing companies and their suppliers

    - The report examines current practices and provides future expectations over the next 12-24 months

    - The research is based on primary survey research conducted by Global Markets Direct in association with ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations

    - Key topics covered include media spend activity, marketing and sales behaviors & strategies by drugs manufacturing companies and their suppliers and how these have been affected by the recession, as well as threats & opportunities, investment outlook and business confidence among both buyers and suppliers.

    - In the report buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats

    - The report provides qualitative analysis of key industry opportunities and threats and contains full survey results

    - The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific and Africa & Middle East

    Highlights

    - 50% of industry players are looking to increase their marketing expenditure over the next 12 months, with only 36% looking to decrease it

    - 32% of industry players are adapting product portfolios or positioning to meet clients cost pressures

    - 59% of companies believe that the demonstration of confidence to their customers from increased marketing activity in the current business climate can give their company an edge

    Reasons to buy

    - Benchmark your sales and marketing plans with industry competitors to effectively determine strategy

    - Identify the specific marketing approaches your competitors are using to win business during the recessionary climate

    - Better promote your business by aligning your capabilities and business practices with your customer's changing needs during these times of market uncertainty

    - Secure stronger customer relationships by understanding the leading business concerns and changing strategies of buyers in the pharmaceutical industry

    - Effectively plan your business strategies

    - Predict how the industry will grow, consolidate and where it will stagnate

    - Uncover the business outlook, key challenges and opportunities identified by suppliers and buyers in the industry

    1 Table of Contents 2

    1.1 List of Tables 5

    1.2 List of Figures 8

    2 Introduction 12

    2.1 What is This Report About? 12

    2.2 Methodology 12

    2.3 Profile Of Survey Respondents 13

    3 Executive Summary 17

    3.1 The Drug Manufacturing Industry is Generally Optimistic About the Recovery of the Global Economy 17

    3.2 The Level of Optimism About Revenue Growth is Marginally Positive Among Both Buyers and Suppliers 17

    3.3 Companies in the Drug Manufacturing Industry Will Be Increasing Marketing Spend Over the Next 12 Months 17

    3.4 Industry Players Face a Number of Key Challenges Due to the Recession 18

    3.5 Suppliers and Buyers in the Pharma Industry Are Adapting Their Marketing and Sales Strategies During Recession to Face Immediate Business Concerns 19

    4 Economic Outlook & Confidence 20

    4.1 Global Economy Recovery Expectations 20

    4.2 Revenue Growth Expectations 24

    5 Drug Manufacturing Industry Investment Outlook 29

    5.1 Fastest & Slowest Growing Markets 29

    5.2 M&A Activity Predictions 36

    5.3 Supplier's Industry Outlook 39

    6 Recession & Recovery: Threats & Opportunities For The Drug Manufacturing Industry 43

    6.1 Leading Business Concerns Due To Recession 43

    6.2 Key Actions To Overcome Business Threats 47

    6.3 Key Actions To Maintain & Win Buyer Business 51

    6.4 Leading Recession & Recovery Related Business Opportunities 60

    7 Marketing Spend Activity 64

    7.1 Annual Marketing Budgets: Suppliers to the Industry 64

    7.2 Expected Change in Marketing Expenditure Levels: Suppliers to the Industry 68

    7.3 Change in Expenditure by Media Channel: Suppliers to the Industry 72

    7.4 Future Investment in Marketing and Sales Technology: Suppliers to the Industry 76

    7.5 Annual Marketing Budgets: Drug Manufacturing Industry Players 82

    7.6 Expected Change in Marketing Expenditure Levels: Drug Manufacturing Industry Players 86

    7.7 Change in Expenditure by Media Channel: Drug Manufacturing Industry Players 90

    7.8 Future Investment in Marketing and Sales Technology: Drug Manufacturing Industry Players 94

    8 Marketing and Sales Behaviors and Strategies and the Impact of Recession and Recovery 100

    8.1 Key Marketing Aims: Suppliers to the Industry 100

    8.2 Marketing and Sales Practices During Recession and Recovery: Suppliers to the Industry 105

    8.3 Expected Adaptations to Marketing Activities During Recession and Recovery: Suppliers to the Industry 109

    8.4 Critical Success Factors for Choosing a Marketing Agency: Suppliers to the Industry 117

    8.5 Marketing Attitudes and Approaches: Suppliers to the Industry 122

    8.6 Key Marketing Aims: Drug Manufacturing Industry Players 124

    8.7 Marketing and Sales Practices During Recession and Recovery: Drug Manufacturing Industry Players 129

    8.8 Expected Adaptations to Marketing Activities During Recession and Recovery: Drug Manufacturing Industry Players 133

    8.9 Critical Success Factors for Choosing a Marketing Agency: Drug Manufacturing Industry Players 141

    8.10 Marketing Attitudes and Approaches: Drug Manufacturing Industry Players 146

    9 Appendix 148

    9.1 Full Survey Results-Closed Questions 148

    9.2 Methodology 154

    9.3 Contact Us 154

    9.4 About Global Markets Direct 154

    9.5 Disclaimer 155

    Table of Contents

    1.1 List of Tables

    Table 1: Count Of Global Drug Manufacturing Industry Survey Respondents By Company Type (Number Of Respondents), 2009 Industry Survey 13

    Table 2: Buyer Respondents By Job Role (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 14

    Table 3: Buyer Respondents By Organization's Global Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 14

    Table 4: Buyer Respondents By Organization's Total Employee Size (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 15

    Table 5: Supplier Respondents By Job Role (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 15

    Table 6: Supplier Respondents By Organization's Global Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 16

    Table 7: Supplier Respondents By Organization's Total Employee Size (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 16

    Table 8: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009 22

    Table 9: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009 24

    Table 10: Company Revenue Growth Optimism By Global Drug Manufacturing Industry Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009 26

    Table 11: Company Revenue Growth Optimism In The Global Drug Manufacturing Industry By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009 28

    Table 12: Drug Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturer Respondents), 2009 31

    Table 13: Outsource Industry (Contract Research Organization / Contract Manufacturing Organization): Market Predictions Of The Fastest And Slowest Growing Regions (% Contract Research Organization / Contract Manufacturing Organization Respondents), 2009 33

    Table 14: Drug Manufacturing Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturing Industry Supplier Respondents), 2009 35

    Table 15: Key Growth Areas In The Global Drug Manufacturing Industry (Analysis Of Supplier Respondents), 2009 Industry Survey 40

    Table 16: Key Growth Areas In The Global Drug Manufacturing Industry (Analysis Of Senior Level Supplier Respondents), 2009 Industry Survey 40

    Table 17: Key Declining Areas In The Global Drug Manufacturing Industry (Analysis Of Supplier Respondents), 2009 Industry Survey 41

    Table 18: Key Declining Areas In The Global Drug Manufacturing Industry (Analysis Of Senior Level Supplier Respondents), 2009 Industry Survey 42

    Table 19: Drug Manufacturer Vs. Contract Research Organization / Contract Manufacturing Organization Vs. Drug Manufacturing Industry Supplier: Leading Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers (% All Respondents), 2009 46

    Table 20: Leading Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009 47

    Table 21: Most Important Actions Being Implemented To Overcome Leading Business Concerns In 2009-2010 In The Global Drug Manufacturing Industry (Analysis Of All Respondents), 2009 48

    Table 22: Most Important Actions Being Implemented To Overcome Leading Business Concerns In 2009-2010 In The Global Drug Manufacturing Industry - Senior Level Responses Only, 2009 49

    Table 23: Most Important Actions Being Implemented By Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations To Overcome Leading Business Concerns In 2009-2010 In The Global Drug Manufacturing Industry (Analysis Of Drug Manufacturer, Contract Research Organization / Contract Manufacturing Organization Respondents), 2009 50

    Table 24: Most Important Actions Being Implemented By Drug Manufacturing Industry Suppliers To Overcome Leading Business Concerns In 2009-2010 In The Global Drug Manufacturing Industry (Analysis Of Drug Manufacturing Industry Suppliers Respondents), 2009 51

    Table 25: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Supplier Responses Versus All Buyer Responses (% All Respondents), 2009 53

    Table 26: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), 2009 55

    Table 27: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of Buyer Respondents By Company Turnover (% Buyer Respondents), 2009 56

    Table 28: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of All Buyer Respondents By Procurement Budget (% Buyer Respondents), 2009 57

    Table 29: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of All Buyer Respondents By Region (% Buyer Respondents), 2009 59

    Table 30: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of All Buyer Respondents By Purchasing Decision Seniority (% Buyer Respondents Purchasing Decision Influence), 2009 60

    Table 31: Leading Business Opportunities During The Recession In The Global Drug Manufacturing Industry (Analysis Of All Respondents), 2009 61

    Table 32: Leading Business Opportunities During The Recession In The Global Drug Manufacturing Industry - Senior Level Responses Only, 2009 62

    Table 33: Leading Business Opportunities For Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations During The Recession In The Global Drug Manufacturing Industry (Analysis Of Buyer Respondents), 2009 63

    Table 34: Leading Business Opportunities For Drug Manufacturing Industry Suppliers During The Recession In The Global Drug Manufacturing Industry (Analysis Of Supplier Respondents), 2009 63

    Table 35: Annual Marketing Budget in US$ by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 66

    Table 36: Annual Marketing Budget in US$ by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 68

    Table 37: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 70

    Table 38: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 71

    Table 39: Expected Increase or Decrease in Expenditure by Media Channel Over the Next 12 Months: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 74

    Table 40: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 79

    Table 41: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 81

    Table 42: Annual Marketing Budget in US$ by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 84

    Table 43: Annual Marketing Budget in US$ by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 85

    Table 44: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 88

    Table 45: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 89

    Table 46: Expected Increase or Decrease in Expenditure by Media Channel Over the Next 12 Months: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 92

    Table 47: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 97

    Table 48: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 99

    Table 49: Key Marketing Aims Over the Next Year: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 101

    Table 50: Most Rated New Media Channels for New Business Generation by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 106

    Table 51: Most Rated New Media Channels for New Business Generation by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 108

    Table 52: Expected Adaptations to Marketing Activities During Recession and Recovery by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 112

    Table 53: Expected Adaptations to Marketing Activities During Recession and Recovery by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 114

    Table 54: Critical Success Factors for Choosing a Marketing Agency by Expected Change in Future Marketing Expenditure (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 120

    Table 55: Critical Success Factors for Choosing a Marketing Agency by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 121

    Table 56: Critical Success Factors for Choosing a Marketing Agency by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 122

    Table 57: Marketing Attitudes and Approaches - Level of Agreement With the Following Statements: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 123

    Table 58: Key Marketing Aims Over the Next Year: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 125

    Table 59: Most Rated New Media Channels for New Business Generation by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 130

    Table 60: Most Rated New Media Channels for New Business Generation by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 132

    Table 61: Expected Adaptations to Marketing Activities During Recession and Recovery by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 136

    Table 62: Expected Adaptations to Marketing Activities During Recession and Recovery by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 138

    Table 63: Critical Success Factors for Choosing a Marketing Agency by Expected Change in Future Marketing Expenditure (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 144

    Table 64: Critical Success Factors for Choosing a Marketing Agency by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 145

    Table 65: Critical Success Factors for Choosing a Marketing Agency by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 146

    Table 66: Marketing Attitudes and Approaches - Level of Agreement With the Following Statements: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 147

    Table 67: Full Survey Results-Closed Questions 148

    Table of Tables

    1.2 List of Figures

    Figure 1: Leading Business Concerns for the Period 2009-2010 Among Global Drug Manufacturing Industry Buyers and Suppliers (% All Respondents), 2009 18

    Figure 2: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings (% All Respondents), 2009 21

    Figure 3: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009 22

    Figure 4: Global Drug Manufacturing Industry Expectations Of Global Economy Recovery Timings By Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009 23

    Figure 5: Company Revenue Growth Optimism In The Global Drug Manufacturing Industry (% All Respondents), 2009 25

    Figure 6: Company Revenue Growth Optimism By Global Drug Manufacturing Industry Company Type: Drug Manufacturers, Contract Research Organizations / Contract Manufacturing Organizations, Drug Manufacturing Industry Suppliers (% All Respondents), 2009 26

    Figure 7: Company Revenue Growth Optimism In The Global Drug Manufacturing Industry By Region: North America, Europe, Asia-Pacific, Rest Of World (% All Respondents), 2009 28

    Figure 8: Drug Manufacturer Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturer Respondents), 2009 30

    Figure 9: Outsource Industry (Contract Research Organization / Contract Manufacturing Organization): Market Predictions Of The Fastest And Slowest Growing Regions (% Contract Research Organization / Contract Manufacturing Organization Respondents), 2009 32

    Figure 10: Drug Manufacturing Industry Supplier Industry: Market Predictions Of The Fastest And Slowest Growing Regions (% Drug Manufacturing Industry Supplier Respondents), 2009 34

    Figure 11: Merger & Acquisition Activity Expectations Over The Next 12 Months In The Global Drug Manufacturer Industry (% Drug Manufacturer Industry Respondents), 2009 37

    Figure 12: Merger & Acquisition Activity Expectations Over The Next 12 Months In The Global Outsource Industry: Contract Research Organization / Contract Manufacturing Organization (% Contract Research Organization / Contract Manufacturing Organization Industry Respondents), 2009 38

    Figure 13: Merger & Acquisition Activity Expectations Over The Next 12 Months In The Global Drug Manufacturing Industry Supplier Industry (% Drug Manufacturing Industry Supplier Industry Respondents), 2009 39

    Figure 14: Leading Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers (% All Respondents), 2009 44

    Figure 15: Drug Manufacturer Vs. Contract Research Organization / Contract Manufacturing Organization Vs. Drug Manufacturing Industry Supplier: Leading Business Concerns For The Period 2009-2010 Among Global Drug Manufacturing Industry Buyers And Suppliers (% All Respondents), 2009 45

    Figure 16: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Supplier Responses Versus All Buyer Responses (% All Respondents), 2009 52

    Figure 17: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Drug Manufacturer Versus Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), 2009 54

    Figure 18: The Most Important Actions For Suppliers To Take To Maintain And Secure Buyer Business During The Recession In The Global Drug Manufacturing Industry: Analysis Of All Buyer Respondents By Region (% Buyer Respondents), 2009 58

    Figure 19: Annual Marketing Budget in US$: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 65

    Figure 20: Annual Marketing Budget in US$ by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 66

    Figure 21: Annual Marketing Budget in US$ by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 67

    Figure 22: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 69

    Figure 23: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 70

    Figure 24: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 71

    Figure 25: Expected Increase or Decrease in Expenditure by Media Channel Over the Next 12 Months: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 73

    Figure 26: Expected Increase in Expenditure by Media Channel Over the Next 12 Months by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 75

    Figure 27: Expected Increase in Expenditure by Media Channel Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 76

    Figure 28: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 77

    Figure 29: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 78

    Figure 30: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 80

    Figure 31: Annual Marketing Budget in US$: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 82

    Figure 32: Annual Marketing Budget in US$ by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 83

    Figure 33: Annual Marketing Budget in US$ by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 85

    Figure 34: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 87

    Figure 35: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 88

    Figure 36: Expected % Change in Marketing Expenditure Levels Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 89

    Figure 37: Expected Increase or Decrease in Expenditure by Media Channel Over the Next 12 Months: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 91

    Figure 38: Expected Increase in Expenditure by Media Channel Over the Next 12 Months by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 93

    Figure 39: Expected Increase in Expenditure by Media Channel Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 94

    Figure 40: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 95

    Figure 41: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 96

    Figure 42: Expected Marketing and Sales Technologies to Invest in Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 98

    Figure 43: Key Marketing Aims Over the Next Year: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 101

    Figure 44: Most Important Key Marketing Aims Over the Next Year by Expected Change in Future Marketing Expenditure (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 102

    Figure 45: Most Important Key Marketing Aims Over the Next Year by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 103

    Figure 46: Most Important Key Marketing Aims Over the Next Year by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 104

    Figure 47: Most Rated New Media Channels for New Business Generation: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 105

    Figure 48: Most Rated New Media Channels for New Business Generation by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 106

    Figure 49: Most Rated New Media Channels for New Business Generation by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 107

    Figure 50: Importance of ROI Metric Types for Measuring Media Campaigns: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 109

    Figure 51: Expected Adaptations to Marketing Activities During Recession and Recovery: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 110

    Figure 52: Expected Adaptations to Marketing Activities During Recession and Recovery by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 111

    Figure 53: Expected Adaptations to Marketing Activities During Recession and Recovery by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 113

    Figure 54: Expected Change in Face-To-Face Meetings Over the Next 12 Months: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 115

    Figure 55: Expected Change in Face-To-Face Meetings Over the Next 12 Months by Company Turnover (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 116

    Figure 56: Expected Change in Face-To-Face Meetings Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 117

    Figure 57: Critical Success Factors for Choosing a Marketing Agency: Drug Manufacturing Industry Supplier (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 118

    Figure 58: Critical Success Factors for Choosing a Marketing Agency by Expected Change in Future Marketing Expenditure (% Supplier Respondents), Global Drug Manufacturing Industry, 2009 119

    Figure 59: Key Marketing Aims Over the Next Year: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 124

    Figure 60: Most Important Key Marketing Aims Over the Next Year by Expected Change in Future Marketing Expenditure (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 126

    Figure 61: Most Important Key Marketing Aims Over the Next Year by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 127

    Figure 62: Most Important Key Marketing Aims Over the Next Year by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 128

    Figure 63: Most Rated New Media Channels for New Business Generation: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 129

    Figure 64: Most Rated New Media Channels for New Business Generation by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 130

    Figure 65: Most Rated New Media Channels for New Business Generation by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 131

    Figure 66: Importance of ROI Metric Types for Measuring Media Campaigns: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 133

    Figure 67: Expected Adaptations to Marketing Activities During Recession and Recovery: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 134

    Figure 68: Expected Adaptations to Marketing Activities During Recession and Recovery by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 135

    Figure 69: Expected Adaptations to Marketing Activities During Recession and Recovery by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 137

    Figure 70: Expected Change in Face-To-Face Meetings Over the Next 12 Months: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 139

    Figure 71: Expected Change in Face-To-Face Meetings Over the Next 12 Months by Company Turnover (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 140

    Figure 72: Expected Change in Face-To-Face Meetings Over the Next 12 Months by Region: North America, Europe, Asia-Pacific, Rest of World (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 141

    Figure 73: Critical Success Factors for Choosing a Marketing Agency: Drug Manufacturer / Contract Research Organization / Contract Manufacturing Organization (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 142

    Figure 74: Critical Success Factors for Choosing a Marketing Agency by Expected Change in Future Marketing Expenditure (% Buyer Respondents), Global Drug Manufacturing Industry, 2009 143

    List of Figures

    To order this report:

    Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery

    ${tempString}

    More market research reports here!

        Contact:
        Nicolas Bombourg
        Reportlinker
        Email: nbo@reportlinker.com
        US: (805)652-2626
        Intl: +1 805-652-2626
    

    SOURCE Reportlinker


    '/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Directors Forum: PEPFAR and the Global AIDS Response
10. Alfacell Corporation to Present at UBS Global Life Sciences Conference
11. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
Breaking Medicine Technology:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and ... to be personalized through a fitness app. The fitness app plans to fix the two ... currently only offer a one size fits all type program , They don’t ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):